Neuronity

health AI / biotech / medtech

Visit website

StageGrant funded

Raised$780,000

Founded2022

Employees2

LocationMansfield, MA

Business modelnot explicitly stated

About

Neuronity is a biotech company dedicated to revolutionizing the treatment of neurodegenerative diseases. With a focus on age-related neurological disorders, such as Parkinson's disease, our cutting-edge gene and cell therapy approach aims to restore healthy immune cell function in aging brains. By targeting the root causes of these conditions, we strive to reduce the unmet needs of patients, families, and caregivers. Our mission is to improve the quality of life for individuals affected by neurodegenerative diseases through groundbreaking interventions and strategic collaborations. Join us in shaping the future of CNS disease therapeutics and making a lasting impact on the lives of millions. #Neuroscience #Biotech #GeneTherapy #CellTherapy #NeurodegenerativeDiseases

Product

Value proposition: Neuronity cures neurological disorders by promoting immunity of the central nervous system and developing therapies to boost healthy immune cells in the aged nervous system to prevent progression of neurodegenerative diseases.

Founders

Hyun Joon Lee — CEO and Founder

Products

therapies to boost CNS immune healthinnovative therapies to enhance immune cells in aged nervous system

Key features

boosting CNS immune activitypreventing progression of neurodegenerative diseasesscientist-led therapy developmentfocus on aging brain

Technologies

immunotherapyneuroimmunologybiotech therapies

Target conditions

neurodegenerative diseasesaging-related neurodegenerationcentral nervous system disorders

Care settings

clinicresearch facilitylaboratory

Investors

The Michael J. Fox FoundationScience Inc.™ Accelerator

News

100 Top Neuroscience Companies · July 2026 - F6S · 2026-07-01T00:00:00.000Z
Tony Fiore - Thoughtful, Experienced Venture Investor, Board ... · 2025-07-15T00:00:00.000Z
Neuronostics Raises £3M to Advance Digital Biomarker Platform - Neuronostics · 2026-06-30T09:15:00.000Z
BioEP - Neuronostics · 2025-04-01T15:08:05.000Z
Neuron23 · 2025-06-23T16:26:14.000Z
Startup For 10: Neuronostics - techSPARK · 2025-07-23T10:14:23.000Z

Browse similar startups

Related startups

Nine Diagnostics — Cambridge, MA
Novastra Therapeutics — Boston, MA
NxtCure — Boston, MA
OncoSys AI — Cambridge, MA
Onduo by Verily — Newton, MA
PeptiFinder Biotech, Inc — Natick, MA
NEVADA CARDIOLOGY ASSOCIATES — Las Vegas, NV
New Care Behavioral Health — Wellington, OH
New Direction — Mount Laurel, NJ
NEW MEXICO CHRONIC DISEASE PREVENTION COUNCIL — Albuquerque, NM
New Vision Eye Clinic — Tulsa, OK
NEXT Diagnostics, Inc. — San Francisco, CA

Profile updated Jul 29, 2026. Sources: neuronitytx.com